Pro Medicus Limited (PMCUF)
OTHER OTC:PMCUF

Pro Medicus Limited (PMCUF) Stock Forecast & Price Target

12 Followers
See the Price Targets and Ratings of:

PMCUF Analyst Ratings

Moderate Buy
2Ratings
1 Buy
1 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Pro
Medicus Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PMCUF Stock 12 Months Forecast

Average Price Target

$39.49
▼(-1.27% Downside)
Based on 2 Wall Street analysts offering 12 month price targets for Pro Medicus Limited in the last 3 months. The average price target is $39.49 with a high forecast of $41.86 and a low forecast of $37.13. The average price target represents a -1.27% change from the last price of $40.00.
Highest Price Target$41.86Average Price Target$39.49Lowest Price Target$37.13
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Wilsons
$41.86
Buy
4.64%
Upside
Reiterated
RBC Capital
$37.81
Hold
-5.49%
Downside
Reiterated
Pro Medicus Ltd. (PME:AU) (PMCUF) PT Raised to AUD56 at RBC CapitalRBC Capital analyst Garry Sherriff raised the price target on Pro Medicus Ltd. (PME:AU) (OTC: PMCUF) to AUD56.00 (from AUD52.00) while maintaining a Sector Perform rating.
Goldman Sachs
$34.84
Hold
-12.91%
Downside
Reiterated
Pro Medicus Ltd. (PME:AU) (PMCUF) PT Raised to AUD51.60 at Goldman SachsGoldman Sachs analyst Chris Cooper raised the price target on Pro Medicus Ltd. (PME:AU) (OTC: PMCUF) to AUD51.60 (from AUD42.60) while maintaining a Neutral rating.
Bell Potter
$37.13
Hold
-7.17%
Downside
Downgraded
Bell Potter downgrades Pro Medicus Limited (PMCUF) to a Hold
Moelis
$38.28
Hold
-4.30%
Downside
Downgraded
Moelis downgrades Pro Medicus Limited (PMCUF) to a Hold
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

PMCUF Financial Forecast

PMCUF Earnings Forecast
Next quarter’s earnings estimate for PMCUF is $0.18 with a range of $0.17 to $0.18. The previous quarter’s EPS was $0.15. PMCUF beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.52% of the time in the same period. In the last calendar year PMCUF has Underperformed its overall industry.
Next quarter’s earnings estimate for PMCUF is $0.18 with a range of $0.17 to $0.18. The previous quarter’s EPS was $0.15. PMCUF beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.52% of the time in the same period. In the last calendar year PMCUF has Underperformed its overall industry.
PMCUF Sales Forecast
Next quarter’s sales forecast for PMCUF is $36.80M with a range of $36.80M to $36.80M. The previous quarter’s sales results were $32.88M. PMCUF beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 42.85% of the time in the same period. In the last calendar year PMCUF has Outperformed its overall industry.
Next quarter’s sales forecast for PMCUF is $36.80M with a range of $36.80M to $36.80M. The previous quarter’s sales results were $32.88M. PMCUF beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 42.85% of the time in the same period. In the last calendar year PMCUF has Outperformed its overall industry.
PMCUF Analyst Recommendation Trends
In the current month, PMCUF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PMCUF average analyst price target in the past 3 months is $39.49
In the current month, PMCUF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PMCUF average analyst price target in the past 3 months is $39.49

PMCUF Stock Forecast FAQ

What is PMCUF’s average 12-month price target, according to analysts?
Based on analyst ratings, Pro Medicus Limited’s 12-month average price target is $39.49.
    What is PMCUF’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for PMCUF, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is PMCUF a Buy, Sell or Hold?
        Pro Medicus Limited has a conensus rating of Moderate Buy which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Pro Medicus Limited’s price target?
          The average price target for Pro Medicus Limited is $39.49. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $41.86 ,the lowest forecast is $37.13. The average price target represents -1.27% Decrease from the current price of $40.
            What do analysts say about Pro Medicus Limited?
            Pro Medicus Limited’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis